title: Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants.
abstract: BACKGROUND
  The aim of this study was to evaluate the indications, results and complications of radiofrequency ablation (RFA) and transcatheter cryoablation (TCA) in neonates and infants with incessant drug-resistant supraventricular tachycardia (SVT).
  
  
  METHODS
  Out of 225 patients who underwent RFA and TCA at our center between January2010 and February 2012, 5 patients under the age of 1 (4 male, 1 female) were evaluated. The indication for RFA/TCA was recurrent hemodynamically compromising drug-resistant SVT.
  
  
  RESULTS
  Over a 2-year period, 6 ablation procedures were performed in 5 patients. Average patient age was 3.3 ± 3.9 months (12 days - 9.5 months); average patient weight was 5.4 ± 2.2 kg (3.5-9 kg). One patient had ventricular septal defect, 1 had corrected transposition of great arteries, ventricular septal defect, right ventricular hypoplasia and pulmonary hypertension, while 3 had only patent foramen ovale. Electrophysiology study showed 1 accessory pathway in each patient (right posteroseptal in 2, left posteroseptal in 2 and left lateral in 1). The pathway was manifest in 1 patient with Wolff-Parkinson-White syndrome (WPW) and concealed in the rest. Two of the concealed pathways had slow conduction time and decremental properties (the permanent form of junctional reciprocating tachycardia). Two patients underwentTCA and 3 - RFA, with an acute success rate of 100%. In the first week after the procedure, the patient with the complex cardiac anomaly and WPW developed recurrence and under went ablation again. Four of the procedures were carried out using an electroanatomic mapping system besides fluoroscopy. Average procedure time was 167 min (100-234); fluoroscopy time was 8.2 min (0.7-19.7). None of the patients developed major complications. After the average follow-upperiod of 6.5 months (3-18), all patients were symptom-free without medication.
  
  
  CONCLUSIONS
  RFA and TCA can be performed successfully in neonates and infants within cessant medically refractory SVT.
authors.affiliation: vtuzcu@gmail.com.
authors.forename: Celal
authors.initials: C
authors.lastname: Akdeniz
authors.forename: Yakup
authors.initials: Y
authors.lastname: Ergul
authors.forename: Neslihan
authors.initials: N
authors.lastname: Kiplapinar
authors.forename: Volkan
authors.initials: V
authors.lastname: Tuzcu
mesh_terms: D058606:Accessory Atrioventricular Bundle / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation / Q000009:adverse effects; D003452:Cryosurgery / Q000009:adverse effects; D004351:Drug Resistance; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D012008:Recurrence; D012086:Reoperation; D013617:Tachycardia, Supraventricular / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D014927:Wolff-Parkinson-White Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery
chemical_list: D000889:Anti-Arrhythmia Agents